Evidence map›Paper›PMID 41572252›Full record

ArticleBMC public health2026

Prevalence and factors associated with uptake of repeat HIV testing among pregnant women in Blantyre, Malawi.

Maria Chifuniro Chikalipo, Martha Patience Kaula, Victor Mwapasa, Alinane Linda Nyondo-Mipando

Abstract read
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria Chifuniro ChikalipoKamuzu University of Health Sciences - School of Maternal, Neonatal and Reproductive Health, Blantyre, Malawi. mchikalipo@kuhes.ac.mw.
Martha Patience KaulaMinistry of Health- Blantyre District Health Office, Blantyre, Malawi.
Victor MwapasaKamuzu University of Health Sciences - School of Global and Public Health, Blantyre, Malawi.
Alinane Linda Nyondo-MipandoKamuzu University of Health Sciences - School of Global and Public Health, Blantyre, Malawi.

Funding

Fogarty International Center of the National Institutes of Health under Award Number D43 TW0010060-01 D43 TW0010060-01
6 · The paper itself

Abstract

introductionRepeat HIV testing during pregnancy is significant to detect new maternal HIV infections and mitigate the risk of mother-to-child HIV transmission. Despite guidelines advocating retesting of initially HIV-negative pregnant women, there is limited information on the implementation of these recommendations. The aim of this study is to assess the magnitude of repeat HIV testing uptake in the third trimester and its associated factors.

methodsWe conducted a convergent parallel mixed method study from November 2021 to April 2022 to determine the prevalence and associated factors for a repeat HIV test among women in the third trimester from Ndirande and Lirangwe primary health facilities in Blantyre. Our quantitative approach involved a retrospective review of antenatal records from July 2020 to June 2021. STATA version 14 was used for descriptive analysis. Frequency distributions, fisher’s tests and multivariable logistic regressions were used to examine the association between repeat HIV testing and selected explanatory variables. The qualitative component was exploratory following phenomenological design. Data were collected from 44 pregnant women and 10 health workers who were purposively selected through focus group discussions in-depth and key informant interviews. Transcripts were coded deductively and inductively manually. The thematic analysis of the data was informed by the Consolidated Framework for Implementation Research (CFIR).

resultsAnalysis of 369 antenatal records, with 302 from Ndirande and 67 from Lirangwe primary health facilities, revealed that only 30 (8.13%) participants received a repeat HIV test in the third trimester from both facilities. Increasing age reduced the likelihood of accessing repeat HIV testing in the third trimester compared to younger women (OR = 0.43; 95% CI: 0.05–3.86). Age, gravidity, and parity did not significantly impact the probability of retesting. Key factors impeding repeat HIV testing included unfamiliarity with the intervention, inadequate resources and clinic operations. In contrast, confirmation of HIV status and improved neonatal outcomes were motivators for repeat HIV testing.

conclusionInformation and counselling on the benefits of repeat HIV testing later in pregnancy is key in increasing uptake and implementation of the service in future pregnancies. In addition, strengthening the clinic operations and improving availability of resources is vital in the implementation and uptake of repeat HIV testing among pregnant women.

Indexed as

HIV InfectionsHIV TestingPatient Acceptance of Health CarePregnancy Complications, InfectiousAdultFemaleFocus GroupsHumansMalawiPregnancyPregnancy Trimester, ThirdPrevalenceRetrospective StudiesYoung AdultHealth systemsRepeat HIV testingSeroconversion and antenatal care

Identifiers

PMID41572252
PMCPMC12911333

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.